Assessing Graves' ophthalmopathy-specific quality of life in Korean patients

被引:43
作者
Choi, Y. J. [1 ]
Lim, H. T. [1 ]
Lee, S. J. [2 ]
Lee, S. Y. [1 ]
Yoon, J. S. [1 ]
机构
[1] Yonsei Univ, Dept Ophthalmol, Coll Med, Inst Vis Res, Seoul 120752, South Korea
[2] Dongguk Univ, Dept Ophthalmol, Ilsan Hosp, Seoul, South Korea
关键词
Graves' ophthalmopathy; quality of life; questionnaire; GO-QOL; DISEASE; QUESTIONNAIRE; MANAGEMENT;
D O I
10.1038/eye.2011.359
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim To investigate the clinical significance of Grave's ophthalmopathy-specific quality of life (GO-QOL) in Korean patients. Methods A cross-sectional study was conducted at the Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea, on 98 consecutive Grave's ophthalmopathy (GO) patients. The GO-QOL survey provided by Terwee and colleagues and suggested by the European group on Graves' orbitopathy (EUGOGO) was translated into Korean language and distributed to study participants. Clinical severity was judged by scores of the modified NOSPECS classification, and inflammatory activity was measured by a seven-point scale of clinical activity score (CAS). Results The mean GO-QOL scores were 73.7 (standard deviation (SD), 26) for visual functioning, 61.9 (SD 26) for appearance, and 67.8 for total quality of life (QOL; SD 22). The worse QOL scores for each part were significantly associated with the higher modified NOSPECS score and CAS after adjusting for confounders such as age and sex (P < 0.05, respectively). In particular, decreased QOL scores for visual function were significantly correlated with a higher grade of extraocular muscle involvement (P < 0.05). Lower QOL scores for appearance were associated with more severe soft-tissue involvement and proptosis (P < 0.05, respectively). Conclusions GO-QOL suggested by EUGOGO showed correlation with objective clinical parameters. GO-QOL can be a simple and effective tool in the evaluation of the clinical and psychological illness of GO patients. Eye (2012) 26, 544-551; doi:10.1038/eye.2011.359; published online 13 January 2012
引用
收藏
页码:544 / 551
页数:8
相关论文
共 14 条
  • [1] Management of Graves' ophthalmopathy: Reality and perspectives
    Bartalena, L
    Pinchera, A
    Marcocci, C
    [J]. ENDOCRINE REVIEWS, 2000, 21 (02) : 168 - 199
  • [2] Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' Orbitopathy
    Bartalena, Luigi
    Baldeschi, Lelio
    Dickinson, Alison J.
    Eckstein, Anja
    Kendall-Taylor, Pat
    Marcocci, Claudio
    Mourits, Maarten P.
    Perros, Petros
    Boboridis, Kostas
    Boschi, Antonella
    Curro, Nicola
    Daumerie, Chantal
    Kahaly, George J.
    Krassas, Gerasimos
    Lane, Carol M.
    Lazarus, John H.
    Marino, Michele
    Nardi, Marco
    Neoh, Christopher
    Orgiazzi, Jacques
    Pearce, Simon
    Pinchera, Aldo
    Pitz, Susanne
    Salvi, Mario
    Sivelli, Paolo
    Stahl, Matthias
    von Arx, Georg
    Wiersinga, Wilmar M.
    [J]. THYROID, 2008, 18 (03) : 333 - 346
  • [3] Evaluation of the national eye institute visual function questionnaire in Graves' ophthalmopathy
    Bradley, Elizabeth A.
    Sloan, Jeff A.
    Novotny, Paul J.
    Garrity, James A.
    Woog, John J.
    West, Sheila K.
    [J]. OPHTHALMOLOGY, 2006, 113 (08) : 1450 - 1454
  • [4] GRAVES OPHTHALMOPATHY - CURRENT CONCEPTS REGARDING PATHOGENESIS AND MANAGEMENT
    BURCH, HB
    WARTOFSKY, L
    [J]. ENDOCRINE REVIEWS, 1993, 14 (06) : 747 - 793
  • [5] Thyrotropin receptor autoantibodies are independent risk factors for graves' ophthalmopathy and help to predict severity and outcome of the disease
    Eckstein, Anja K.
    Plicht, Marco
    Lax, Hildegard
    Neuhaeuser, Markus
    Mann, Klaus
    Lederbogen, Sebastian
    Heckmann, Christian
    Esser, Joachim
    Morgenthaler, Nils G.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) : 3464 - 3470
  • [6] Quality of life in patients with Graves' ophthalmopathy is markedly decreased: Measurement by the medical outcomes study instrument
    Gerding, MN
    Terwee, CB
    Dekker, FW
    Koornneef, L
    Prummel, MF
    Wiersinga, WM
    [J]. THYROID, 1997, 7 (06) : 885 - 889
  • [7] K-Jafari Alireza, 2010, Binocul Vis Strabismus Q, V25, P217
  • [8] Lee Hun, 2010, Korean J Ophthalmol, V24, P65, DOI 10.3341/kjo.2010.24.2.65
  • [9] Assessing quality of life in Australian patients with Graves' ophthalmopathy
    Park, JJ
    Sullivan, TJ
    Mortimer, RH
    Wagenaar, M
    Perry-Keene, DA
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (01) : 75 - 78
  • [10] GRAVES OPHTHALMOPATHY IN RELATION TO CIGARETTE-SMOKING AND ETHNIC-ORIGIN
    TELLEZ, M
    COOPER, J
    EDMONDS, C
    [J]. CLINICAL ENDOCRINOLOGY, 1992, 36 (03) : 291 - 294